Results 81 to 90 of about 3,978,530 (165)

Acceptance and Commitment Therapy with Psilocybin-Assisted Therapy: Healing through Psychological Flexibility [PDF]

open access: yes
In this paper, I will explore the integration of acceptance and commitment therapy (ACT) with psilocybin-assisted therapy. These two standalone treatments have demonstrated research- supported efficacy for depression, anxiety, and substance use.
Patterson, Brooke
core  

Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients

open access: yesFrontiers in Psychiatry
Cancer patients arrive for psilocybin therapy with bodies altered by illness and treatment — bodies that they have learned to brace against, dissociate from, or scan for threat.
Anthony L. Back   +4 more
doaj   +1 more source

Cancer Neuroscience: From Hallmark‐Enabling Biology to a Therapeutic Pillar

open access: yes
Advanced Oncology, Volume 1, Issue 1, December 2026.
Moran Amit
wiley   +1 more source

Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis

open access: yes, 2023
International audienceAbstractBackgroundThe present study explored the acceptability of psilocybin‐assisted group therapy from the perspective of patients with cancer and depression who participated in a clinical trial assessing the safety and efficacy ...
Agrawal, Manish   +10 more
core   +1 more source

With great power comes great responsibility: Promise and caution in the new psychedelic renaissance

open access: yesBrain Disorders
Clinicians and researchers are showing increased interest in psychedelic-assisted therapy for patients who don't show improvement from using conventional antidepressants.
Matthew Halma, Rakeem Levy, Joseph Varon
doaj   +1 more source

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part IV. Psilocybin

open access: yes, 2023
Background: The primary psychoactive drug in magic mushrooms, psilocybin induces profound alterations in consciousness through its action at the 5-HT2A receptor.
Chelsey Fasano   +7 more
core   +1 more source

Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)

open access: yesBrain Sciences
Background/Objectives: Psilocybin has re-emerged as a promising intervention for neuropsychiatric disorders including major depressive disorder, treatment-resistant depression, anxiety associated with life-threatening illness, obsessive compulsive ...
Piotr Skalski   +3 more
doaj   +1 more source

MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments

open access: yes
Australia became the first country to establish a national regulatory pathway permitting authorised psychiatrists to prescribe 3,4-methylenedioxymethamphetamine (MDMA) for post-traumatic stress disorder (PTSD) and psilocybin for treatment-resistant ...
Octavian Victor Brinzei
core   +1 more source

The Forgotten Past Inspiring the Future: Revisiting the Potential of Psilocybin Therapy

open access: yes, 2021
In this paper, I explore the use of psilocybin-assisted therapy while working with cancer patients and individuals struggling with treatment-resistant anxiety, depression, and substance use.
Hildebrandt, Scott
core  

An Introduction to Psilocybin Assisted Therapy for the Physician Assistant

open access: yes
Cultures have been experimenting with psychedelics for thousands of years(1). After the introduction of psychedelics in the United States in the 1950’s for the treatment of mental disorders, these substances and their use in clinical studies were later ...
Shaw, Austin Taylor
core   +1 more source

Home - About - Disclaimer - Privacy